Literature DB >> 2726683

Nonlinear distribution of atenolol between plasma and cerebrospinal fluid.

F M Gengo1, S C Fagan, L N Hopkins, D Wagner, D P Schuster.   

Abstract

Long Evans rats were given atenolol doses ranging from 0.27 to 5.4 mg/kg by intraperitoneal injection Animals were dosed once every 2 hr for a total of five doses. Atenolol concentrations 1 hr after the last dose were measured from simultaneously obtained plasma and cerebrospinal fluid (CSF) samples CSF concentrations of atenolol were not proportional to plasma concentrations. The ratio of CSF/plasma concentrations was higher (0.33) at lower plasma atenolol levels (less than 100 ng/ml) than at the higher atenolol plasma levels (0.05) (P less than 0.001). The relationship between plasma and cerebrospinal fluid atenolol concentrations was best described by the sum of a Michaelis-Menten and linear function. Animals were also given atenolol doses and then subjected to global cerebral ischemia. The relationship of atenolol concentrations from plasma and CSF in these animals was linear, with a constant partition ratio of 0.02. Together these data show that atenolol partitioning between plasma and CSF is nonlinear and possibly an energy-dependent process.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2726683     DOI: 10.1023/a:1015973719096

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Beta-adrenoceptor blockers and the blood-brian barrier.

Authors:  G Neil-Dwyer; J Bartlett; J McAinsh; J M Cruickshank
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

2.  An investigation of the comparative liposolubilities of beta-adrenoceptor blocking agents.

Authors:  P B Woods; M L Robinson
Journal:  J Pharm Pharmacol       Date:  1981-03       Impact factor: 3.765

3.  A new model of bilateral hemispheric ischemia in the unanesthetized rat.

Authors:  W A Pulsinelli; J B Brierley
Journal:  Stroke       Date:  1979 May-Jun       Impact factor: 7.914

4.  Studies on the uptake and binding of propranolol by rat tissues.

Authors:  D W Schneck; J F Pritchard; A H Hayes
Journal:  J Pharmacol Exp Ther       Date:  1977-12       Impact factor: 4.030

5.  Blockade of the central 5-HT autoreceptor by beta-adrenoceptor antagonists.

Authors:  D N Middlemiss
Journal:  Eur J Pharmacol       Date:  1986-01-14       Impact factor: 4.432

6.  Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists.

Authors:  E A Taylor; D Jefferson; J D Carroll; P Turner
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

7.  Lipid-soluble and water-soluble beta-blockers. Comparison of the central nervous system depressant effect.

Authors:  F M Gengo; L Huntoon; W B McHugh
Journal:  Arch Intern Med       Date:  1987-01

8.  Central effects of beta-adrenoceptor antagonists.

Authors:  S A Salem; D G McDevitt
Journal:  Clin Pharmacol Ther       Date:  1983-01       Impact factor: 6.875

9.  Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.

Authors:  O Lyngstam; L Rydén
Journal:  Acta Med Scand       Date:  1981

10.  Blood-brain barrier transport and brain sequestration of propranolol and lidocaine.

Authors:  W M Pardridge; R Sakiyama; G Fierer
Journal:  Am J Physiol       Date:  1984-09
View more
  1 in total

1.  Ignoring pharmacokinetics may lead to isoboles misinterpretation: illustration with the norfloxacin-theophylline convulsant interaction in rats.

Authors:  Miren Cadart; Sandrine Marchand; Claudine Pariat; Serge Bouquet; William Couet
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.